414
Views
1
CrossRef citations to date
0
Altmetric
Review

The complications of treating chronic obstructive pulmonary disease in low income countries of sub-Saharan Africa

ORCID Icon, , , , & ORCID Icon
Pages 227-237 | Received 05 Nov 2017, Accepted 02 Jan 2018, Published online: 10 Jan 2018

References

  • Beaglehole R, Bonita R, Horton R, et al. Priority actions for the non-communicable disease crisis. Lancet. 2011;377(9775):1438–1447.
  • Beaglehole R, Bonita R, Alleyne G, et al. UN high-level meeting on non-communicable diseases: addressing four questions. Lancet. 2011;378(9789):449–455.
  • World Health Organization. NCD mortality and morbidity, Global Health Observatory (GHO) data, 2015. 2015. [cited 2017 Sept 18]. Available from: http://www.who.int/gho/ncd/mortality_morbidity/en/
  • World Health Organization. Global status report in noncommunicable diseases. Geneva, Switzerland: WHO press. 2014.
  • KPMG. The state of healthcare in Africa. 2012. [cited 2017 Sep 18]. Available from: https://www.kpmg.com/Africa/en/IssuesAndInsights/Articles-Publications/Documents/The-State-of-Healthcare-in-Africa.pdf
  • Bischoff A, Ekoe T, Perone N, et al. Chronic disease management in sub-Saharan Africa: whose business is it? Int J Environ Res Public Health. 2009;6(8):2258–2270.
  • Beran D, Zar HJ, Perrin C, et al. Forum of international respiratory societies working group collaboration. Burden of asthma and chronic obstructive pulmonary disease and access to essential medicines in low-income and middle-income countries. Lancet Respir Med. 2015;3(2):159–170.
  • Bousquet J, Dahl R, Khaltaev N. Global alliance against chronic respiratory diseases. Allergy. 2007;62(3):216–223.
  • World Health Organization. Chronic obstructive pulmonary disease (COPD), Fact sheet November 2016. 2016. [cited 2017 Sept 18]. Available from: http://www.who.int/mediacentre/factsheets/fs315/en/
  • World Health Organization. Asthma fact sheet 2017. 2017. [Accessed 2017 Sept]. Available from: http://www.who.int/mediacentre/factsheets/fs307/en/
  • WHO fact sheet. The top 10 causes of death, 2014. [cited 2017 Sept 18]. Available from: http://who.int/mediacentre/factsheets/fs310/en/
  • GBD. Mortality and causes of death collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1459–1544.
  • Pleasants RA, Riley IL, Mannino DM. Defining and targeting health disparities in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2016;11:2475–2496.
  • Torres-Duque CA. Poverty cannot be inhaled and it is not a genetic condition. How can it be associated with chronic airflow obstruction? Eur Respir J. 2017;49(6). DOI:10.1183/13993003.00823-2017
  • Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2017. [cited 2017 Sept 18]. Available from: http://www.goldcopd.org/
  • Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009 Aug 29;374(9691):733–743.
  • Eisner MD, Anthonisen N, Coultas D, et al. An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;182(5):693–718.
  • Allwood B, Calligaro G. Pathogenesis of chronic obstructive pulmonary disease: an African perspective. S Afr Med J. 2015;105(9):789.
  • Svanes C, Sunyer J, Plana E, et al. Early life origins of chronic obstructive pulmonary disease. Thorax. 2010;65(1):14–20.
  • Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370(9589):765–773.
  • Menezes AMB, Perez-Padilla R, Jardim JRB, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005;366(9500):1875–1881.
  • Buist AS, Vollmer WM, McBurnie MA. Worldwide burden of COPD in high- and low-income countries. Part I. The burden of obstructive lung disease (BOLD) initiative. Int J Tuberc Lung Dis. 2008;12(7):703–708.
  • van Gemert F, van der Molen T, Jones R, et al. The impact of asthma and COPD in sub-Saharan Africa. Prim Care Respir J. 2011;20:240–248.
  • Finney LJ, Feary JR, Leonardi-Bee J, et al. Chronic obstructive pulmonary disease in sub-Saharan Africa: a systematic review. Int J Tuberc Lung Dis. 2013;17(5):583–589.
  • Adeloye D, Basquill C, Papana A, et al. An estimate of the prevalence of COPD in Africa: a systematic analysis. Copd. 2015;12(1):71–81.
  • Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;370(9589):741–750.
  • Fullerton DG, Suseno A, Semple S, et al. Wood smoke exposure, poverty and impaired lung function in Malawian adults. Int J Tuberc Lung Dis. 2011;15(3):391–398.
  • Musafiri S, Van Meerbeeck J, Musango L, et al. Prevalence of atopy, asthma and COPD in an urban and a rural area of an African country. Respir Med. 2011;105(11):1596–1605.
  • Obaseki DO, Erhabor GE, Gnatiuc L, et al. Chronic airflow obstruction in a black African population: results of BOLD Study, Ile-Ife, Nigeria. Copd. 2016;13(1):42–49
  • van Gemert F, Kirenga B, Chavannes N, et al. Prevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (FRESH AIR Uganda): a prospective cross-sectional observational study. Lancet Glob Health. 2015;3(1):e44–51.
  • Meghji J, Nadeau G, Davis KJ, et al. Noncommunicable lung disease in sub-Saharan Africa. A community-based cross-sectional study of adults in urban Malawi. Am J Respir Crit Care Med. 2016 Jul 1;194(1):67–76.
  • Pefura-Yone EW, Kengne AP, Balkissou AD, et al. Prevalence of obstructive lung disease in an African country using definitions from different international guidelines: a community based cross-sectional survey. BMC Res Notes. 2016;9: 124-015-1731-6.
  • World Bank. Databank. 2016. [cited 2017 Oct 9]. Available from: https://data.worldbank.org/indicator/SP.POP.TOTL?page=2
  • North CM, Kakuhikire B, Vorechovska D, et al. Prevalence and correlates of obstructive lung disease in rural Uganda: a population-based cross-sectional study, poster ATS conference. Am J Respir Crit Care Med, Abstract Issue. 2016;193:A2003.
  • Ministry of Health. Uganda clinical guidelines 2014: national guidelines for management of common conditions. [cited 2017 Sept 18]. Available from: http://apps.who.int/medicinedocs/en/m/abstract/Js21741en/
  • van Gemert F, Chavannes N, Nabadda N, et al. Impact of chronic respiratory symptoms in a rural area of sub-Saharan Africa: an in-depth qualitative study in the Masindi district of Uganda. Prim Care Respir J. 2013;22(3):300–305.
  • Cazzola M, Bettoncelli G, Sessa E, et al. Prevalence of comorbidities in patients with chronic obstructive pulmonary disease. Respiration. 2010;80(2):112–119.
  • Yin HL, Yin SQ, Lin QY, et al. Prevalence of comorbidities in chronic obstructive pulmonary disease patients: a meta-analysis. Medicine (Baltimore). 2017;96(19):e6836.
  • Babar ZU, Lessing C, Mace C, et al. The availability, pricing and affordability of three essential asthma medicines in 52 low- and middle-income countries. Pharmacoeconomics. 2013;31(11):1063–1082.
  • Kibirige D, Kampiire L, Atuhe D, et al. Access to affordable medicines and diagnostic tests for asthma and COPD in sub Saharan Africa: the Ugandan perspective. BMC Pulm Med. 2017;17(1): 179-017-0527-y.
  • World Health Organization. Package of noncommunicable disease intervention for primary health care in low-resource settings 2010. Geneva, Swizterland: WHO press; 2010. ISBN 978 92 4 159899 6.
  • Uganda Bureau of Statistics. Global Adult Tobacco Survey (GATS). Uganda: executive summary 2013; 2014.
  • Kabwama SN, Ndyanabangi S, Mutungi G, et al. Tobacco use and associated factors among Adults in Uganda: findings from a nationwide survey. Tob Induc Dis. 2016;14: 27-016-0093-8, eCollection 2016
  • Kirenga BJ, Jones R, Muhofa A, et al. Rapid assessment of the demand and supply of tobacco dependence pharmacotherapy in Uganda. Public Health Action. 2016;6(1):35–37.
  • World Health Organization. Global health observatory. 2016. [cited 2017 Oct 9]. Available from: http://www.who.int/countries
  • Alemseged F, Haileamlak A, Tegegn A, et al. Risk factors for chronic non-communicable diseases at Gilgel Gibe field research center, southwest Ethiopia: population based study. Ethiop J Health Sci. 2012;22(S):19–28.
  • Reda AA, Kotz D, Biadgilign S. Adult tobacco use practice and its correlates in eastern Ethiopia: a cross-sectional study. Harm Reduct J. 2013;10:28-7517-10-28.
  • Kenya National Bureau of Statistics. Global Adult Tobacco Survey (GATS) executive summary 2014. The Tobacco Control Unit, Division on Non-communicable Diseases, Ministry of Health, Nairobi, Kenya; 2015.
  • Kenya Ministry of Health. Kenya STEPwise survey for non communicable diseases risk factor 2015 report. Division of Non-communicable Diseases, Ministry of Health, Nairobi, Kenya; 2016.
  • Gichuki JW, Opiyo R, Mugyenyi P, et al. Healthcare providers’ level of involvement in provision of smoking cessation interventions in public health facilities in Kenya. J Public Health Afr. 2015;6(2):523.
  • World Health Organization. Joint national capacity assessment in the implementation of effective tobacco control policies in Kenya. Geneva, Switzerland: WHO press; 2012.
  • Salvi S, Barnes PJ. Is exposure to biomass smoke the biggest risk factor for COPD globally? Chest. 2010;138(1):3–6.
  • Fullerton DG, Bruce N, Gordon SB. Indoor air pollution from biomass fuel smoke is a major health concern in the developing world. Trans R Soc Trop Med Hyg. 2008;102(9):843–851.
  • Kurmi OP, Lam KB, Ayres JG. Indoor air pollution and the lung in low- and medium-income countries. Eur Respir J. 2012;40(1):239–254.
  • Gordon SB, Bruce NG, Grigg J, et al. Respiratory risks from household air pollution in low and middle income countries. Lancet Respir Med. 2014;2(10):823–860.
  • Amegah AK, Jaakkola JJ. Household air pollution and the sustainable development goals. Bull World Health Organ. 2016;94(3):215–221.
  • Lopez-Campos JL, Marquez-Martin E, Soriano JB. The role of air pollution in COPD and implications for therapy. Expert Rev Respir Med. 2016;10(8):849–859.
  • Thurston GD, Kipen H, Annesi-Maesano I, et al. A joint ERS/ATS policy statement: what constitutes an adverse health effect of air pollution? An analytical framework. Eur Respir J. 2017;49(1): Print. 2017 Jan.doi:10.1183/13993003.00419-2016
  • Austin KA, Mejia MT. Household air pollution as a silent killer: women’s status and solid fuel use in developing nations. Popul Environ. 2017.
  • World Health Organization. WHO guidelines for indoor air quality: household fuel combustion. Geneva, Switzerland: WHO press; 2014. ISBN 978 92 4 154887 8.
  • Pope D, Bruce N, Dherani M, et al. Real-life effectiveness of ‘improved’ stoves and clean fuels in reducing PM2.5 and CO: systematic review and meta-analysis. Environ Int. 2017;101:7–18.
  • Quansah R, Semple S, Ochieng CA, et al. Effectiveness of interventions to reduce household air pollution and/or improve health in homes using solid fuel in low-and-middle income countries: a systematic review and meta-analysis. Environ Int. 2017;103:73–90.
  • Bakke PS, Ronmark E, Eagan T, et al. Recommendations for epidemiological studies on COPD. Eur Respir J. 2011;38(6):1261–1277.
  • Stanojevic S, Wade A, Stocks J. Reference values for lung function: past, present and future. Eur Respir J. 2010;36(1):12–19.
  • Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95 year age range: the global lung function 2012 equations. Eur Respir J. 2012.
  • Quanjer PH. Lung function, race and ethnicity: a conundrum. Eur Respir J. 2013;41(6):1249–1251.
  • van Gemert FA, Kirenga B, Jones R. The significance of early-life prevention of COPD in sub-Saharan Africa: findings from the FRESH AIR UGANDA survey. The African J Respir Med. 2016;11(2):4.
  • Rennard SI, Drummond MB. Early chronic obstructive pulmonary disease: definition, assessment, and prevention. Lancet. 2015;385(9979):1778–1788.
  • Postma DS, Bush A. van den Berge M. Risk factors and early origins of chronic obstructive pulmonary disease. Lancet. 2015;385(9971):899–909.
  • Gray D, Willemse L, Visagie A, et al. Determinants of early-life lung function in African infants. Thorax. 2017;72(5):445–450.
  • Smith KR, McCracken JP, Weber MW, et al. Effect of reduction in household air pollution on childhood pneumonia in Guatemala (RESPIRE): a randomised controlled trial. Lancet. 2011;378(9804):1717–1726.
  • Agusti A, Noell G, Brugada J, et al. Lung function in early adulthood and health in later life: a transgenerational cohort analysis. Lancet Respir Med. 2017;5(12):935–945.
  • World Health Organization. Tobacco and poverty: a vicious circle. Geneva, Switzerland: WHO press; 2004.
  • World Health Organization. Tobacco, fact sheet No 339, July 2015. [updated 2017 May; Cited 2017 Oct 9]. Available from: http://www.who.int/mediacentre/factsheets/fs339/en/.
  • Amegah AK, Agyei-Mensah S. Urban air pollution in sub-Saharan Africa: time for action. Environ Pollut. 2017;220(Pt A):738–743.
  • Landrigan PJ, Fuller R, Acosta NJR, et al. The Lancet Commission on pollution and health. Lancet. 2017. [Published 2017 Oct 19; Cited 2017 Dec 6]. Available from: http://dx.doi.org/10.1016/S0140-6736(17)32345-0
  • Grigsby M, Siddharthan T, Chowdhury MA, et al. Socioeconomic status and COPD among low- and middle-income countries. Int J Chron Obstruct Pulmon Dis. 2016;11:2497.
  • Townend J, Minelli C, Mortimer K, et al. The association between chronic airflow obstruction and poverty in 12 sites of the multinational BOLD study. Eur Respir J. 2017;49(6). DOI:10.1183/13993003.01880-2016
  • Amaral AF, Coton S, Kato B, et al. TB associated with both airflow obstruction and low lung function: bold results. Eur Respir J. 2015;46(4):1104–1112.
  • Sarkar M, Srinivasa C, Madabhavi I, et al. Tuberculosis associated chronic obstructive pulmonary disease. Clin Respir J. 2017;11(3):285–295.
  • Drummond MB, Kirk GK. HIV-associated lung diseases: insights and implications for the clinician. Lancet Respir Med. 2014;2(7):58392.
  • Lalloo UG, Pillay S, Mngqibisa R, et al. HIV and COPD: a conspiracy of risk factors. Respirology. 2016;21(7):1166–1172.
  • Barter DM, Agboola SO, Murray MB, et al. Tuberculosis and poverty: the contribution of patient costs in sub-Saharan Africa–a systematic review. BMC Public Health. 2012;12:980-2458-12-980.
  • Mbirimtengerenji ND. Is HIV/AIDS epidemic outcome of poverty in sub-Saharan Africa? Croat Med J. 2007;48(5):605–617.
  • Fishwick D, Sen D, Barber C, et al. Occupational chronic obstructive pulmonary disease: a standard of care. Occup Med (Lond). 2015;65(4):270–282.
  • Silva R, Oyarzun M, Olloquequi J. Pathogenic mechanisms in chronic obstructive pulmonary disease due to biomass smoke exposure. Arch Bronconeumol. 2015;51(6):285–292.
  • Camp PG, Ramirez-Venegas A, Sansores RH, et al. COPD phenotypes in biomass smoke- versus tobacco smoke-exposed Mexican women. Eur Respir J. 2014;43(3):725–734.
  • Perez-Padilla R, Ramirez-Venegas A, Sansores-Martinez R. Clinical characteristics of patients with biomass-associated COPD and chronic bronchitis 2004-2104. J COPD Found. 2014;1:1.
  • Warwick H, Alison D. Smoke: the killer in the kitchen; air pollution in developing countries. 2004; London, UK: ITDG Publishing. ISBN 1 85339 588 9. Available from. http://www.itdgpublishing.org.uk
  • Perez-Padilla R, Schilmann A, Riojas-Rodriguez H. Respiratory health effects of indoor air pollution. Int J Tuberc Lung Dis. 2010;14(9):1079–1086.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.